Published in Am J Physiol on May 01, 1999
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet (2001) 2.51
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry (1994) 2.41
Out-patient Treatment of Early Syphilis with Penicillin. Br Med J (1946) 2.40
A new paradigm for graduate research and training in the biomedical sciences and engineering. Adv Physiol Educ (2005) 2.19
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest (2001) 2.16
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol (2001) 2.13
Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg (2000) 2.03
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry (2000) 1.93
Distribution, propagation, and coordination of contractile activity in lymphatics. Am J Physiol (1993) 1.92
Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A (2001) 1.84
Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry (1994) 1.84
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull (1983) 1.81
Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79
A psychobiological perspective on the personality disorders. Am J Psychiatry (1991) 1.76
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol (1995) 1.69
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68
Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology (2001) 1.61
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry (1998) 1.60
Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg (1996) 1.58
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry (1996) 1.52
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry (1997) 1.51
Omental transposition in chronic spinal cord injury. Spinal Cord (1996) 1.49
Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res (1992) 1.45
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest (1997) 1.45
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry (2001) 1.43
Venous air embolism in patients with pulmonary barotrauma. Crit Care Med (1994) 1.42
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem (1995) 1.41
Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J (1999) 1.41
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry (1991) 1.41
Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery. Thorac Cardiovasc Surg (2002) 1.40
Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Arch Gen Psychiatry (1993) 1.39
Mechanisms of killing of spores of Bacillus subtilis by iodine, glutaraldehyde and nitrous acid. J Appl Microbiol (2000) 1.39
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry (1998) 1.39
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry (1999) 1.36
Cardiovascular responses to elevation of intra-abdominal hydrostatic pressure. Am J Physiol (1985) 1.35
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. Trans R Soc Trop Med Hyg (1991) 1.34
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology (1988) 1.32
The pattern of breathing during successful and unsuccessful trials of weaning from mechanical ventilation. Am Rev Respir Dis (1986) 1.31
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol (2003) 1.30
Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A (2009) 1.29
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem (1983) 1.28
Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry (1985) 1.27
Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. Trans R Soc Trop Med Hyg (1992) 1.26
Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg (2000) 1.26
Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res (2005) 1.24
Postmortem studies in schizophrenia. Schizophr Bull (1998) 1.23
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci (1982) 1.21
In vitro studies of membrane protein folding. Crit Rev Biochem Mol Biol (2001) 1.21
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry (1986) 1.20
Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry (1994) 1.19
Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J (1995) 1.18
Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res (1999) 1.18
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A (2000) 1.17
Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res (1991) 1.16
Physostigmine: improvement of long-term memory processes in normal humans. Science (1978) 1.16
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry (1987) 1.16
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Arch Neurol (2001) 1.15
Survey of the UK veterinary profession: common species and conditions nominated by veterinarians in practice. Vet Rec (2014) 1.15
Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis (1990) 1.15
Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis (1993) 1.14
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry (2001) 1.14
Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology (1996) 1.13
The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Compr Psychiatry (2001) 1.13
A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Dis Assoc Disord (1989) 1.13
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol Psychiatry (2007) 1.12
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet (1996) 1.12
Systematic root cause analysis of adverse drug events in a tertiary referral hospital. Jt Comm J Qual Improv (2000) 1.11
Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5. Structure (2001) 1.11
Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma. Biochem Pharmacol (1994) 1.10
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am J Med Genet (1999) 1.09
The validity of the family history method for identifying Alzheimer disease. Arch Neurol (1997) 1.09
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res (1992) 1.09
Reactive oxygen metabolites inhibit spontaneous lymphatic contractions. Am J Physiol (1991) 1.08
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry (2001) 1.08
Lymphocyte function in major depressive disorder. Arch Gen Psychiatry (1984) 1.07
Physostigmine in mania. Arch Gen Psychiatry (1978) 1.07
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res (1993) 1.07
Myocardial fluid balance. Eur J Cardiothorac Surg (2001) 1.06
Management of the presumed susceptible varicella (chickenpox)-exposed gravida: a cost-effectiveness/cost-benefit analysis. Obstet Gynecol (1996) 1.06
Tepid sponging to reduce temperature in febrile children in a tropical climate. Clin Pediatr (Phila) (1994) 1.05
Characteristics of very poor outcome schizophrenia. Am J Psychiatry (1987) 1.05
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry (1997) 1.04
Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci U S A (1993) 1.03
Single case study. Possible organophosphate-induced parkinsonism. J Nerv Ment Dis (1978) 1.03